Viromed Medical AG (Q11) — Cash Flow Reinvestment Rate
Latest as of December 2024:
4.82x
Viromed Medical AG (Q11) has a Cash Flow Reinvestment Rate of 4.82x as of December 2024, reinvesting €35.91 Million (capex €35.91 Million ) from operating cash flow of €7.45 Million. See free cash flow generation of Viromed Medical AG to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
4.82x
(Capex + Investments) / Operating CF
Total Reinvested
€35.91 Million
Capex + Investments
Operating Cash Flow
€7.45 Million
EUR
Capital Expenditures
€35.91 Million
EUR
Annual Cash Flow Reinvestment Rate for Viromed Medical AG (None–None)
Year-by-year capital reinvestment analysis for Viromed Medical AG. See Q11 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow